Log in to save to my catalogue

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spon...

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spon...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8177391da8e429dad2e74f305ed0ff6

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

About this item

Full title

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2021-04, Vol.10 (4), p.845

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Salivary gland tumors are a heterogeneous group of neoplasms representing less than 10% of all head and neck tumors. Among salivary gland tumors, salivary duct carcinoma (SDC) is a rare, but highly aggressive malignant tumor resembling ductal breast carcinoma. Sublingual treatments are promising for SDC due to the induction of both local and system...

Alternative Titles

Full title

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d8177391da8e429dad2e74f305ed0ff6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8177391da8e429dad2e74f305ed0ff6

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells10040845

How to access this item